Swift FDA Approval Can Complicate Reimbursement Efforts, Consultant Says

Rapid FDA approval of Johnson & Johnson/Depuy's Charité artificial disc contributed to early reimbursement setbacks for the device, according to Quorum Consulting Senior Consultant Barbara Santry